Infectious Disease
RSSArticles
-
Who Can Receive the Non-mRNA COVID-19 Vaccine Now?
The FDA recently limited the use of the Janssen COVID-19 vaccine.
-
COVID-19 Exacerbated Antimicrobial Resistance
CDC report indicates related infections and deaths rose 15% in hospitals in 2020.
-
Two-Dose Novavax Added to List of U.S. COVID-19 Vaccines
The FDA issued an emergency use authorization for the fourth vaccine.
-
HPV Vaccination Rate Needs Improvement
The prevalence of HPV infections and their sequelae remain high, although this is a problem that is preventable with available vaccines.
-
Cardiology Groups Standardize COVID-19 Diagnosis, Treatment Definitions
Guide provides clinicians with uniform information on symptom recognition, risk factors, testing, and more.
-
Infectious Disease Alert Updates
How Much Should Injectable Cabotegravir for PrEP Cost? Asymptomatic COVID Infection in Healthcare Workers
-
Is There Value in Repeating Blood Cultures While the First Set Is Still Incubating?
The yield from repeat blood cultures is low, suggesting their general use in most patients should be discouraged.
-
Getting to the NBA Finals by COVID-19 Vaccine Boosting
Vaccine booster doses were highly effective in preventing infection, whether symptomatic or asymptomatic, with the omicron variant of SARS-CoV-2 in National Basketball Association players and staff.
-
Cirrhosis and Infections
Infections in patients with cirrhosis are frequent and potentially lethal, with pneumonia associated with the highest risk for mortality.
-
Influenza Vaccination Reduces the Risk of Major Cardiovascular Events
A meta-analysis of six randomized, controlled trials revealed receipt of influenza vaccination reduced the risk of major cardiovascular events compared to the unvaccinated, with 56 patients needing vaccination to prevent one event. Higher-risk patients had 45% reduced risk.